AAAAAA
Results:
1-11
|
Results: 11
Authors:
Myerson, RJ
Valentini, V
Birnbaum, EH
Cellini, N
Coco, C
Fleshman, JW
Gambacorta, MA
Genovesi, D
Kodner, IJ
Picus, J
Ratkin, GA
Read, TE
Citation: Rj. Myerson et al., A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma, INT J RAD O, 50(5), 2001, pp. 1299-1308
Authors:
Myerson, RJ
Singh, A
Birnbaum, EH
Fry, RD
Fleshman, JW
Kodner, IJ
Lockett, MA
Picus, J
Walz, BJ
Read, TE
Citation: Rj. Myerson et al., Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer, INT J RAD O, 50(3), 2001, pp. 665-674
Authors:
Myerson, RJ
Kong, FM
Birnbaum, EH
Fleshman, JW
Kodner, IJ
Picus, J
Ratkin, GA
Read, TE
Walz, BJ
Citation: Rj. Myerson et al., Radiation therapy for epidermoid carcinoma of the anal canal, clinical andtreatment factors associated with outcome, RADIOTH ONC, 61(1), 2001, pp. 15-22
Authors:
Zon, RT
McClean, J
Helman, D
Ansari, R
Picus, J
Sandler, A
Williams, SD
Loehrer, PJ
Citation: Rt. Zon et al., Altretamine for the treatment of metastatic renal cell carcinoma - A Hoosier Oncology Group trial, INV NEW DR, 19(3), 2001, pp. 229-231
Authors:
Naughton, M
Picus, J
Zhu, XP
Catalona, WJ
Vollmer, RT
Humphrey, PA
Citation: M. Naughton et al., Scatter factor-hepatocyte growth factor elevation in the serum of patientswith prostate cancer, J UROL, 165(4), 2001, pp. 1325-1328
Authors:
Read, TE
McNevin, MS
Gross, EKM
Whiteford, HM
Lewis, JL
Ratkin, G
Picus, J
Birnbaum, EH
Fleshman, JW
Kodner, IJ
Myerson, RJ
Citation: Te. Read et al., Neoadjuvant therapy for adenocarcinoma of the rectum: Tumor response and acute toxicity, DIS COL REC, 44(4), 2001, pp. 513-522
Authors:
Miller, KD
Picus, J
Blanke, C
John, W
Clark, J
Shulman, LN
Thornton, D
Rowinsky, E
Loehrer, PJ
Citation: Kd. Miller et al., Phase II study of the multitargeted antifolate LY231514 (ALIMTA (TM), MTA,pemetrexed disodium) in patients with advanced pancreatic cancer, ANN ONCOL, 11(1), 2000, pp. 101-103
Authors:
John, W
Picus, J
Blanke, CD
Clark, JW
Schulman, LN
Rowinsky, EK
Thornton, DE
Loehrer, PJ
Citation: W. John et al., Activity of multitargeted antifolate (Pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma - Results from a phase II study, CANCER, 88(8), 2000, pp. 1807-1813
Authors:
Kantoff, PW
Halabi, S
Conaway, M
Picus, J
Kirshner, J
Hars, V
Trump, D
Winer, EP
Vogelzang, NJ
Citation: Pw. Kantoff et al., Hydrocortisone with or without mitoxantrone in men with hormone-refractoryprostate cancer: Results of the Cancer and Leukemia Group B 9182 study, J CL ONCOL, 17(8), 1999, pp. 2506-2513
Authors:
Myerson, RJ
Genovesi, D
Lockett, MA
Birnbaum, E
Fleshman, J
Fry, R
Kodner, I
Menteer, J
Picus, J
Read, T
Walz, B
Citation: Rj. Myerson et al., Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: Long-term tumor control and tolerance to treatment, INT J RAD O, 43(3), 1999, pp. 537-543
Authors:
Picus, J
Schultz, M
Citation: J. Picus et M. Schultz, Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractoryprostate cancer: Preliminary results, SEMIN ONCOL, 26(5), 1999, pp. 14-18
Risultati:
1-11
|